Moderna, Inc. (MRNA) has a consensus analyst rating of Hold, based on 27 analysts covering the stock. Of those, 8 recommend buying, 15 recommend holding, and 4 recommend selling.
The analyst consensus price target for MRNA is $35.67, representing a -32.5% downside from the current price of $52.84. Price targets range from a low of $17.00 to a high of $63.00.
